As of 2026-09-19, the Relative Valuation of Haemonetics Corp (HAE) is 80.39 USD. This relative valuation is based on P/E multiples. With the latest stock price at 108.40 USD, the upside of Haemonetics Corp based on Relative Valuation is -25.8%.
The range of the Relative Valuation is 69.06 - 99.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.6x - 44.7x | 35.0x |
| Forward P/E multiples | 28.4x - 35.7x | 31.0x |
| Fair Price | 69.06 - 99.71 | 80.39 |
| Upside | -36.3% - -8.0% | -25.8% |
| Date | P/E |
| 2026-09-18 | 51.17 |
| 2026-09-17 | 50.79 |
| 2026-09-16 | 50.15 |
| 2026-09-15 | 50.13 |
| 2026-09-14 | 50.18 |
| 2026-09-11 | 48.47 |
| 2026-09-10 | 47.70 |
| 2026-09-09 | 48.69 |
| 2026-09-08 | 48.54 |
| 2026-09-04 | 48.58 |
| 2026-09-03 | 48.55 |
| 2026-09-02 | 48.58 |
| 2026-09-01 | 48.12 |
| 2026-08-31 | 48.65 |
| 2026-08-28 | 49.07 |
| 2026-08-27 | 49.56 |
| 2026-08-26 | 50.32 |
| 2026-08-25 | 51.13 |
| 2026-08-24 | 51.17 |
| 2026-08-21 | 51.36 |
| 2026-08-20 | 51.08 |
| 2026-08-19 | 51.17 |
| 2026-08-18 | 49.40 |
| 2026-08-17 | 42.61 |
| 2026-08-14 | 42.86 |
| 2026-08-13 | 42.66 |
| 2026-08-12 | 43.11 |
| 2026-08-11 | 41.17 |
| 2026-08-10 | 40.88 |
| 2026-08-07 | 41.46 |
| 2026-08-06 | 40.13 |
| 2026-08-05 | 39.46 |
| 2026-08-04 | 40.30 |
| 2026-08-03 | 40.97 |
| 2026-07-31 | 40.38 |
| 2026-07-30 | 40.04 |
| 2026-07-29 | 40.32 |
| 2026-07-28 | 38.96 |
| 2026-07-27 | 37.72 |
| 2026-07-24 | 37.19 |
| 2026-07-23 | 36.53 |
| 2026-07-22 | 36.83 |
| 2026-07-21 | 36.85 |
| 2026-07-20 | 36.90 |
| 2026-07-17 | 36.75 |
| 2026-07-16 | 37.05 |
| 2026-07-15 | 36.19 |
| 2026-07-14 | 35.12 |
| 2026-07-13 | 36.29 |
| 2026-07-10 | 35.96 |